SEC Form 4 · accession 0001368993-17-000006
WaferGen Bio-systems, Inc. · WGBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Alan Schueren
Director
Period of report
Jan 3, 2017
Accepted (ET)
Jan 4, 2017 · 8:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001368993
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 3, 2017 | A | 3,049 | $0.00 | A | 8,368 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents grant of restricted stock units. 100% of the restricted stock units vest on December 31, 2017, unless the grantee ceases service as a director before the vesting date, in which event the award shall become vested pro rata (based on the number of days between January 1, 2017, and the date of cessation of services, divided by 365) on the date of cessation of services; provided in the event of a Corporate Transaction or Change in Control, one hundred percent (100%) of the Units shall become fully vested as of immediately prior to the effective date of such Corporate Transaction or Change in Control.
- F2These RSUs are held by the reporting person as nominee and for the benefit of Montclaire Partners.
Remarks
Exhibit 24 - Power of Attorney